A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mg
Janssen-Cilag Pty Ltd
The primary objective of this study is to compare, the number of patients with heartburn and
regurgitation symptom resolution after treatment with either rabeprazole 20 mg, esomeprazole
20 mg or esomeprazole 40 mg.
Study Comparing Esomeprazole Associated With Sodium Bicarbonate From Eurofarma and Esomeprazole in Treatment of Gastroesophageal Reflux Disease ESOBIC
Eurofarma Laboratorios S.A.
A phase III, randomized, open-label, superiority study comparing the incremental product
esomeprazole associated with sodium bicarbonate made by Eurofarma and Nexium® in the
treatment of gastroesophageal reflux disease. The study will enroll 94 patients in each arm
(total of 188 patients).
Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
Fundação de Amparo à Pesquisa do Estado de São Paulo
The purpose of this study is to assess whether the switch from branded to generic warfarin
or between different generic warfarin tablets may cause fluctuation in the results of
coagulation tests (International Normalized Rate, acronym INR) in patients, thus
predisposing them to unnecessary risks.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.